Uncategorized

The House Energy & Commerce Committee’s (E&C) reconciliation draft (text and summary) seems to largely align with our expectations regarding cuts / risks in Medicaid, Obamacare, and pharmacy benefit managers (PBM).  While there were still…

On the heels of the UK trade deal announced this morning, we have the following updates on: China trade talks; The U.S. Court of International Trade reciprocal trade case; and Potential semiconductor tariffs. On trade…

Apropos of our note on the subject earlier today, there are reports this afternoon that as early as Monday, May 12 President Trump “is expected to sign an executive order directing aides to pursue ……

The list of potential state and federal legislative threats to pharmacy benefit managers (PBMs) [CI, CVS, UNH, ELV, GDRX] seems to be growing, even though there has not been widespread enactment of these bills. Putting…

We continue to give ~75% odds that the reconciliation/ tax bill is likely to pass Congress this summer and to include many other tax provisions than just those from the 2017 Tax Cuts and Jobs…

We continue to assign ~35% odds to Congress including Medicaid Most Favored Nation (MFN) price controls into its broader reconciliation bill given: (A) the complexities of such a policy; (B) the expedited timeline lawmakers are…

Notwithstanding a recent CMS memo advising insurers to design their Obamacare plan bids assuming expiration of the enhanced premium subsidies at year-end, we remain optimistic that Congress ultimately settles on a middle ground (revision and…

This week, with the not-so-surprising postponements of key House committee reconciliation markups, the focus will be on cobbling together a reconciliation bill. We could see a major trade deal announced this week. There is some…

We believe President Trump’s “skinny budget” proposal, released today, is mostly dead on arrival and could easily lead to a government shutdown at year’s end or early next year. We expect a more detailed version…

With GKOS shares down pre-market amid questions on its earnings call last night regarding the Medicare policy issues affecting iDose and iStent sales, we offer the following takeaways: We generally agree with the company that,…